88IV - PR Newswire Asia's news - Health Care/Hospital

< Previous page

| Title only | Print

Next page >

ZEISS Medical Technology and Aier Eye Hospital Group Sign Strategic Agreement for 25 VISUMAX 800 Units JENA, Germany , June 18, 2026 /PRNewswire/ -- ZEISS Medical Technology announced today that the company held a signing ceremony with the Aier Eye Hospital Group, entering into a strategic agreement for ... 2026-06-18T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Tinnitus Quest Builds Momentum with Oxford Research Study, New Funding Call, and Second Tinnitus Hackathon OXFORD, England , June 18, 2026 /PRNewswire/ -- Tinnitus Quest , an international patient-driven nonprofit dedicated to accelerating research into treatments to silence tinnitus, today announced the ... 2026-06-18T Health Care/Hospital Medical/Pharmaceuticals
Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969, Achieving First Clinical Milestone in Collaboration with Hygtia Therapeutics CAMBRIDGE, Mass. and HONG KONG , June 17, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage biotechnology company powered by generative artificial intelligence ... 2026-06-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin Major regulatory milestone paves the way for commercialization and marks first step toward broader CxM biomarker sensing strategy ... 2026-06-17T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat STOCKHOLM , June 17, 2026 /PRNewswire/ -- Gesynta Pharma AB, a Swedish clinical stage pharmaceutical company focusing on chronic inflammatory diseases, today announced that 50% of the target of 190 ... 2026-06-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ligufalimab (CD47)-Based Combination Achieves Deep Responses and Survival Benefit in Frontline AML: Phase II Results Presented in Oral Session at EHA 2026 HONG KONG , June 17, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that compelling results from its randomized, double-blind, placebo-controlled ... 2026-06-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
APAC healthcare systems face growing strain as rising patient expectations collide with stretched clinical workforce - Bain & Company survey 95% of consumers want a single touchpoint to manage their healthcare 84% of consumers expect greater convenience from healthcare system Three in four consumers comfortable with AI-enabled healthcare ... 2026-06-17T Banking/Financial Service Computer/Electronics Health Care/Hospital
RRS® HA Long Lasting awarded Best Injectable in Skin Revitalization at AMWC 2026, reinforcing Skin Tech Pharma Group's leadership in the Skin Builder category BARCELONA, Spain , June 17, 2026 /PRNewswire/ -- Skin Tech Pharma Group proudly announces that its flagship injectable, RRS® HA LONG LASTING, has been recognized as Best Injectable in the Skin Revitalization ... 2026-06-17T Cosmetics & Personal Care Health Care/Hospital Medical/Pharmaceuticals
Ping An Good Doctor Upgrades AI Doctor Service "Ping An AI Doctor", Expanding Access to Ping An Ecosystem's 90 Million MAUs HONG KONG , June 17, 2026 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or the "Company", Stock Code: 1833.HK) has recently upgraded its ... 2026-06-17T Computer Software Computer/Electronics Health Care/Hospital
Dioseve Secures JPY 1.45 Billion to Advance iPS Cell‑Based IVF Support, Adds TIME100 Scientist as Advisor Funding round and NEDO Deep Tech Startup Support Program selection will support development and clinical adoption of DIOS ‑ 101, an iPS cell ‑ derived co ‑ culture designed to reduce the burden of ... 2026-06-17T Biotechnology Health Care/Hospital

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved